David R. Bauer
Lawyers
Filters
First American Financial $450 million senior notes offering
The 5.45% investment-grade notes are due 2034
Labcorp $2 billion senior notes offering
The investment-grade notes are due 2030, 2032 and 2034
MBX Biosciences $188 million IPO
The shares are listed on the Nasdaq Global Select Market
Terns Pharmaceuticals $173 million stock and pre-funded warrants offering
The shares are listed on the Nasdaq Global Select Market
Ionis Pharmaceuticals $500.3 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Illumina $500 million notes offering
The 4.65% investment-grade notes are due 2026
Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
The exchangeable notes are due 2030
Eli Lilly $5 billion notes offering
The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064
ANI Pharmaceuticals $316.25 million convertible notes offering
We advised ANI Pharmaceuticals on the offering
Precigen $34 million follow-on offering
We advised Precigen on the SEC-registered offering